Researchers call for financial incentives to speed confirmatory trials for accelerated approvals
Biopharma companies that win new accelerated approvals typically have no financial incentive to complete their confirmatory trial because the price of the treatment doesn’t change …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.